行情

FMS

FMS

费森尤斯医疗
NYSE

实时行情|Nasdaq Last Sale

41.54
-0.39
-0.93%
交易中 14:20 06/18 EDT
开盘
41.46
昨收
41.93
最高
41.81
最低
41.37
成交量
35.74万
成交额
--
52周最高
46.55
52周最低
31.50
市值
243.33亿
市盈率(TTM)
18.27
分时
5日
1月
3月
1年
5年
费森尤斯新一代ECMO正式上市
健康时报客户端 · 05/31 03:12
摩根大通表示,现在买这些“便宜”的全球股票的窗口很短
There's a type of stock that's trading "near the bottom," according to JPMorgan.
CNBC.com · 05/27 14:51
Deals of the day-Mergers and acquisitions
reuters.com · 05/21 14:45
German stocks - Factors to watch on May 21
reuters.com · 05/21 05:04
策略师警告,提防ESG评级–超越它们,寻找最值得购买的股票
Many companies get high ESG ratings simply because they release relevant information, asset management firm Bernstein said.
CNBC.com · 05/19 02:01
欧洲有望在今年击败所有主要市场。以下是摩根士丹利在该地区的精选推荐
Morgan Stanley analysts picked stocks that have a large international presence, but trade at a discount to their global peers.
CNBC.com · 05/18 23:23
15个欧洲股息贵族使您的投资组合多样化
By, Derek English
Benzinga · 05/18 18:28
-瑞士信贷将费森尤斯医疗的价格目标从62欧元上调至68欧元,维持中性评级
MT Newswires · 05/10 10:32
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解FMS最新的财务预测,通过FMS每股收益,每股净资产,每股现金流等数据分析费森尤斯医疗近期的经营情况,然后做出明智的投资选择。
分析师评级

5位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测FMS价格均价为38.10,最高价位44.98,最低价为35.98。
EPS
机构持股
总机构数: 260
机构持股: 2,048.71万
持股比例: 3.50%
总股本: 5.86亿
类型机构数股数
增持
52
174.17万
建仓
36
971.21万
减持
33
115.00万
平仓
43
114.53万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设施与服务
-1.31%
医疗保健提供商与服务
-1.30%
高管信息
Chairman - Supervisory/Director
Dieter Schenk
Chairman - Management/Chief Executive Officer
Rice Powell
Non-Executive Chairman
Ben Lipps
Vice Chairman - Supervisory/Independent Director
Rolf Classon
Chief Financial Officer/Management Board
Helen Giza
Corporate Executive
Harry De Wit
Vice President - Research & Development/Management Board
Olaf Schermeier
Management Board
Harry de Wit
Management Board
Frank Maddux
Management Board
Katarzyna Mazur-Hofsaess
Management Board
William Valle
Management Board
Kent Wanzek
Independent Director/Supervisory Board
William Johnston
Supervisory Board
Deborah McWhinney
Independent Director/Supervisory Board
Dorothea Wenzel
Independent Director/Supervisory Board
Pascale Witz
Supervisory Board
Gregor Zund
Supervisory Board
Gregor Zuend
公告日期
每股分红
除权日期
--
每股分红:USD 0.573191
2021/05/24
2020/08/12
每股分红:USD 0.497802
2020/08/28
2019/05/08
每股分红:USD 0.450194
2019/05/17
2018/05/10
每股分红:USD 0.427
2018/05/21
2017/05/17
每股分红:USD 0.37
2017/05/11
2016/05/16
每股分红:USD 0.313
2016/05/10
2015/05/21
每股分红:USD 0.298
2015/05/15
2014/05/19
每股分红:USD 0.368
2014/05/13
2013/05/20
每股分红:USD 0.334
2013/05/14
  • 全部
  • 财务报告
  • 内部人交易
更多
FMS 简况
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

微牛提供Fresenius Medical Care AG & Co. KGaA(NYSE-FMS)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的FMS股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易FMS股票基本功能。